Home › BIO Launches Survey on FDA/Sponsor Interactions During Drug Development
 

Keywords :   


BIO Launches Survey on FDA/Sponsor Interactions During Drug Development

2014-08-06 06:00:00| Industrial Newsroom - All News for Today

BIO announced survey tool on FDA/Sponsor Interactions During Drug Development to better inform policy initiatives designed to improve FDA and drug sponsor coordination and communication during drug development. Survey will serve to inform next reauthorization of the Prescription Drug User Fee Act VI. By helping to identify areas where policies, regulations, and practices are working well and areas that need improvement, sponsor input will make process more efficient and effective. This story is related to the following:Trade Associations

Tags: development survey drug bio

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
07.11Remnants of Fourteen-E Graphics
07.11Remnants of Fourteen-E Forecast Discussion Number 6
07.11Remnants of Fourteen-E Wind Speed Probabilities Number 6
07.11Remnants of Fourteen-E Public Advisory Number 6
07.11Summary for Remnants of Fourteen-E (EP4/EP142024)
07.11Remnants of Fourteen-E Forecast Advisory Number 6
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Advisory Number 17
More »